vs
Side-by-side financial comparison of Mastech Digital, Inc. (MHH) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $45.5M, roughly 1.3× Mastech Digital, Inc.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -83.0%, a 85.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -10.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -1.5%).
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
MHH vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.5M | $57.3M |
| Net Profit | $972.0K | $-47.5M |
| Gross Margin | 28.3% | 91.6% |
| Operating Margin | 2.2% | -82.2% |
| Net Margin | 2.1% | -83.0% |
| Revenue YoY | -10.4% | 36.9% |
| Net Profit YoY | 227.3% | -9.6% |
| EPS (diluted) | $0.08 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $45.5M | $57.3M | ||
| Q3 25 | $48.5M | $51.3M | ||
| Q2 25 | $49.1M | $48.5M | ||
| Q1 25 | $48.3M | $32.7M | ||
| Q4 24 | $50.7M | $41.8M | ||
| Q3 24 | $51.8M | $33.3M | ||
| Q2 24 | $49.5M | $29.1M | ||
| Q1 24 | $46.8M | $26.0M |
| Q4 25 | $972.0K | $-47.5M | ||
| Q3 25 | $941.0K | $-52.9M | ||
| Q2 25 | $135.0K | $-46.6M | ||
| Q1 25 | $-1.4M | $-49.5M | ||
| Q4 24 | $297.0K | $-43.3M | ||
| Q3 24 | $1.9M | $-43.6M | ||
| Q2 24 | $1.4M | $-32.3M | ||
| Q1 24 | $-161.0K | $-141.4M |
| Q4 25 | 28.3% | 91.6% | ||
| Q3 25 | 27.8% | 89.3% | ||
| Q2 25 | 28.1% | 88.6% | ||
| Q1 25 | 26.7% | 88.8% | ||
| Q4 24 | 29.0% | 90.9% | ||
| Q3 24 | 28.5% | 88.5% | ||
| Q2 24 | 28.2% | 89.9% | ||
| Q1 24 | 25.9% | 89.2% |
| Q4 25 | 2.2% | -82.2% | ||
| Q3 25 | 1.7% | -102.6% | ||
| Q2 25 | 0.1% | -93.4% | ||
| Q1 25 | -3.8% | -143.7% | ||
| Q4 24 | 0.1% | -98.6% | ||
| Q3 24 | 4.7% | -132.0% | ||
| Q2 24 | 3.4% | -139.2% | ||
| Q1 24 | -0.9% | -538.7% |
| Q4 25 | 2.1% | -83.0% | ||
| Q3 25 | 1.9% | -103.1% | ||
| Q2 25 | 0.3% | -96.1% | ||
| Q1 25 | -3.0% | -151.4% | ||
| Q4 24 | 0.6% | -103.6% | ||
| Q3 24 | 3.6% | -131.2% | ||
| Q2 24 | 2.8% | -110.9% | ||
| Q1 24 | -0.3% | -544.4% |
| Q4 25 | $0.08 | $-0.73 | ||
| Q3 25 | $0.08 | $-0.82 | ||
| Q2 25 | $0.01 | $-0.75 | ||
| Q1 25 | $-0.12 | $-0.81 | ||
| Q4 24 | $0.01 | $-0.71 | ||
| Q3 24 | $0.16 | $-0.73 | ||
| Q2 24 | $0.12 | $-0.55 | ||
| Q1 24 | $-0.01 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $89.3M | $139.1M |
| Total Assets | $111.8M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.5M | $388.9M | ||
| Q3 25 | $32.7M | $416.1M | ||
| Q2 25 | $27.9M | $291.0M | ||
| Q1 25 | $24.7M | $314.5M | ||
| Q4 24 | $27.7M | $320.6M | ||
| Q3 24 | $23.9M | $298.4M | ||
| Q2 24 | $20.6M | $319.1M | ||
| Q1 24 | $19.4M | $201.2M |
| Q4 25 | $89.3M | $139.1M | ||
| Q3 25 | $88.0M | $148.8M | ||
| Q2 25 | $87.8M | $-11.9M | ||
| Q1 25 | $86.9M | $18.9M | ||
| Q4 24 | $87.4M | $21.7M | ||
| Q3 24 | $86.5M | $11.2M | ||
| Q2 24 | $84.0M | $39.3M | ||
| Q1 24 | $81.7M | $61.6M |
| Q4 25 | $111.8M | $480.2M | ||
| Q3 25 | $112.6M | $506.9M | ||
| Q2 25 | $110.4M | $372.7M | ||
| Q1 25 | $110.1M | $386.7M | ||
| Q4 24 | $111.5M | $392.3M | ||
| Q3 24 | $111.5M | $363.6M | ||
| Q2 24 | $107.5M | $381.8M | ||
| Q1 24 | $106.1M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $4.3M | — |
| FCF MarginFCF / Revenue | 9.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 4.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | $10.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $-25.4M | ||
| Q3 25 | $6.5M | $-26.6M | ||
| Q2 25 | $3.3M | $-23.3M | ||
| Q1 25 | $-3.0M | $-40.4M | ||
| Q4 24 | $4.0M | $-18.8M | ||
| Q3 24 | $3.3M | $-25.2M | ||
| Q2 24 | $1.2M | $-29.1M | ||
| Q1 24 | $-1.3M | $-40.7M |
| Q4 25 | $4.3M | — | ||
| Q3 25 | $6.3M | — | ||
| Q2 25 | $3.2M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $707.0K | — | ||
| Q1 24 | $-1.6M | — |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | -6.4% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | -3.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 4.48× | — | ||
| Q3 25 | 6.88× | — | ||
| Q2 25 | 24.41× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.60× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MHH
| IT Staffing Services | $37.6M | 83% |
| Data And Analytics Services | $7.8M | 17% |
RYTM
Segment breakdown not available.
